• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

S Afr J Infect Dis . Changing character and waning impact of COVID-19 at a tertiary centre in Cape Town, South Africa

tetano

Editor, Senior Moderator
S Afr J Infect Dis


. 2023 Dec 18;38(1):550.
doi: 10.4102/sajid.v38i1.550. eCollection 2023. Changing character and waning impact of COVID-19 at a tertiary centre in Cape Town, South Africa

Lucas E Hermans[SUP] 1 [/SUP], Petro Booysen[SUP] 2 [/SUP], Linda Boloko[SUP] 2 [/SUP], Marguerite Adriaanse[SUP] 3 [/SUP], Timothy J de Wet[SUP] 4 [/SUP], Aimee R Lifson[SUP] 5 [/SUP], Naweed Wadee[SUP] 2 [/SUP], Nectarios Papavarnavas[SUP] 6 [/SUP], Gert Marais[SUP] 7 8 [/SUP], Nei-Yuan Hsiao[SUP] 7 [/SUP], Michael-Jon Rosslee[SUP] 9 [/SUP], Gregory Symons[SUP] 10 [/SUP], Gregory L Calligaro[SUP] 10 [/SUP], Arash Iranzadeh[SUP] 11 [/SUP], Robert J Wilkinson[SUP] 2 12 13 [/SUP], Ntobeko A B Ntusi[SUP] 1 14 [/SUP], Carolyn Williamson[SUP] 15 [/SUP], Mary-Ann Davies[SUP] 16 17 [/SUP], Graeme Meintjes[SUP] 1 2 [/SUP], Sean Wasserman[SUP] 2 18 [/SUP]



Affiliations
Abstract

Background: The emergence of genetic variants of SARS-CoV-2 was associated with changing epidemiological characteristics throughout coronavirus disease 2019 (COVID-19) pandemic in population-based studies. Individual-level data on the clinical characteristics of infection with different SARS-CoV-2 variants in African countries is less well documented.
Objectives: To describe the evolving clinical differences observed with the various SARS-CoV-2 variants of concern and compare the Omicron-driven wave in infections to the previous Delta-driven wave.
Method: We performed a retrospective observational cohort study among patients admitted to a South African referral hospital with COVID-19 pneumonia. Patients were stratified by epidemiological wave period, and in a subset, the variants associated with each wave were confirmed by genomic sequencing. Outcomes were analysed by Cox proportional hazard models.
Results: We included 1689 patients were included, representing infection waves driven predominantly by ancestral, Beta, Delta and Omicron BA1/BA2 & BA4/BA5 variants. Crude 28-day mortality was 25.8% (34/133) in the Omicron wave period versus 37.1% (138/374) in the Delta wave period (hazard ratio
0.68 [95% CI 0.47-1.00] p = 0.049); this effect persisted after adjustment for age, gender, HIV status and presence of cardiovascular disease (adjusted HR [aHR] 0.43 [95% CI 0.28-0.67] p < 0.001). Hospital-wide SARS-CoV-2 admissions and deaths were highest during the Delta wave period, with a decoupling of SARS-CoV-2 deaths and overall deaths thereafter.
Conclusion: There was lower in-hospital mortality during Omicron-driven waves compared with the prior Delta wave, despite patients admitted during the Omicron wave being at higher risk.
Contribution: This study summarises clinical characteristics associated with SARS-CoV-2 variants during the COVID-19 pandemic at a South African tertiary hospital, demonstrating a waning impact of COVID-19 on healthcare services over time despite epidemic waves driven by new variants. Findings suggest the absence of increasing virulence from later variants and protection from population and individual-level immunity.

Keywords: COVID-19; Delta; Omicron; SARS-CoV-2; clinical characteristics; observational study.

 
Back
Top Bottom